Evan Roberts Sells 3,519 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 3,519 shares of the company’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $30.06, for a total transaction of $105,781.14. Following the completion of the sale, the chief operating officer now directly owns 741,197 shares in the company, valued at $22,280,381.82. This trade represents a 0.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total transaction of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Stock Performance

Shares of Phreesia stock opened at $28.20 on Friday. The business’s 50 day moving average price is $27.29 and its 200 day moving average price is $23.84. The company has a market cap of $1.64 billion, a price-to-earnings ratio of -19.18 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.58) EPS. On average, research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Hedge Funds Weigh In On Phreesia

Institutional investors have recently bought and sold shares of the company. Deerfield Management Company L.P. Series C grew its stake in shares of Phreesia by 133.6% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company’s stock valued at $31,999,000 after buying an additional 727,384 shares during the period. Greenhouse Funds LLLP grew its position in Phreesia by 27.9% in the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after acquiring an additional 626,579 shares during the period. Park West Asset Management LLC purchased a new position in Phreesia in the fourth quarter worth approximately $10,657,000. Millennium Management LLC increased its stake in Phreesia by 83.2% during the fourth quarter. Millennium Management LLC now owns 653,634 shares of the company’s stock worth $16,445,000 after acquiring an additional 296,863 shares during the last quarter. Finally, ExodusPoint Capital Management LP raised its position in Phreesia by 448.6% in the fourth quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company’s stock valued at $4,402,000 after purchasing an additional 143,077 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Robert W. Baird reduced their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. KeyCorp lifted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Finally, Needham & Company LLC reissued a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. Thirteen analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.